Orders shipped same day
HSA/ FSA Accepted

How to Tackle Eczema: 12 Evidence-Based Strategies That Work

How to Tackle Eczema: 12 Evidence-Based Strategies That Work

By Jessica Arenas, Lead Research Analyst •

Treatment-resistant eczema affects 30% of chronic sufferers, leaving them cycling through failed prescriptions and mounting frustration. Research demonstrates that mean adherence rates drop to only 32% by eight weeks of treatment[1], while comprehensive approaches achieve 67-75% effectiveness rates in resistant cases[2]. Understanding how to tackle eczema systematically changes everything.

Your journey through multiple failed treatments isn't unusual. Research reveals that treatment expectations were met only partially, or not at all, in 75% of eczema patients across 10 countries[3]. You've likely tried steroid creams, prescription moisturizers, elimination diets, and natural remedies. Each disappointment affects more than your skin. Studies confirm that patients with atopic dermatitis experience significantly higher levels of anxiety and depression[4]. Your expertise from this difficult journey is valuable. Now, emerging research offers new pathways forward.

This guide presents 12 evidence-based strategies to tackle eczema comprehensively, backed by research showing that multi-targeted approaches achieve superior outcomes in treatment-resistant cases[5]. You'll discover breakthrough findings about skin barrier repair, learn how your microbiome affects treatment success, and get actionable steps for systematic trigger identification that reduces flare frequency by 65%[6]. You'll also learn how identifying your personal triggers fits into a comprehensive management plan. Each strategy is supported by peer-reviewed research and designed for real-world implementation. Whether newly diagnosed or struggling for years, these approaches offer practical solutions based on clinical evidence.

A breakthrough 2024 study revealed that comprehensive treatment approaches combining barrier repair with microbiome support achieved 72% improvement rates in previously treatment-resistant cases[7]. This multi-targeted strategy represents a new paradigm for achieving sustained skin health and breaking the cycle of failed treatments.

Key Takeaways

  • 30% of chronic eczema cases resist conventional treatments - requiring comprehensive, multi-targeted approaches
  • Skin barrier repair combined with microbiome support - improves outcomes by up to 70% in resistant cases
  • Proper moisturizing technique matters more than product choice - apply within 3 minutes of bathing for optimal absorption
  • Trigger identification and avoidance - reduces flare frequency by 65% when systematically implemented
  • Mental health support enhances physical healing - stress management improves treatment response by 45%

Table of Contents

First, Understand Your Eczema to Tackle It Effectively

Before implementing any treatment strategy, understanding your specific eczema type determines which approaches will work best. Research on atopic dermatitis phenotypes and endotypes reveals multiple classification systems based on age, IgE levels, severity, race, skin barrier function, and immune response patterns[8].

Atopic dermatitis is the most common form of eczema, typically requiring barrier repair and anti-inflammatory treatments[9]. Other important types include seborrheic dermatitis and dyshidrotic eczema, each requiring specific management approaches. Contact dermatitis represents another major category that primarily needs trigger identification and avoidance[10].

Research Update: Research demonstrates that accurate diagnosis is a prerequisite for optimal patient management, as different types of dermatitis and eczema may require different therapeutic strategies, ultimately enabling more effective disease management[11].

Severity assessment guides treatment intensity. The SCORAD (Scoring Atopic Dermatitis) system, used in clinical settings, evaluates:

  • Affected body surface area
  • Intensity of symptoms (redness, swelling, crusting)
  • Subjective symptoms (itch and sleep loss)

Research demonstrates that preventive measures involving frequent application of moisturizers and avoidance of triggering factors form the foundation of atopic dermatitis management[12]. Moderate to severe cases (SCORAD over 25) typically require medical interventions alongside lifestyle modifications[13].

Strategy 1: Repair Your Skin Barrier Function

Your skin barrier acts as your body's first defense line. In eczema, this barrier becomes compromised, allowing moisture to escape and irritants to penetrate. Research demonstrates that filaggrin gene mutations are a major genetic factor affecting barrier function in atopic dermatitis patients[14].

The 3-Minute Moisturizing Rule

Timing matters more than you might think. Research indicates that the timing of post-bath moisturizer application significantly affects skin hydration outcomes[15].

The optimal technique involves:

  1. Pat dry gently - leave skin slightly damp
  2. Apply liberally - use 30-60ml for full body coverage
  3. Use downward strokes - prevents pore clogging
  4. Layer if needed - apply second coat to extra-dry areas

Research indicates that proper moisturizer application techniques enhance skin barrier function and significantly reduce transepidermal water loss in patients with atopic dermatitis[16].

What Ingredients Help Repair the Skin Barrier?

Not all moisturizers work equally for barrier repair. Research identifies key ingredients that actively restore barrier function:

82%

improvement seen with ceramide-containing moisturizers in clinical studies

Ceramides, naturally occurring lipids in healthy skin, show remarkable efficacy. A randomized controlled trial found ceramide-dominant moisturizers improved barrier function comparable to mild topical steroids[17].

Other proven ingredients include:

  • Niacinamide - improves skin barrier function and reduces inflammation[18]
  • Hyaluronic acid - holds 1000 times its weight in water
  • Colloidal oatmeal - provides anti-inflammatory and soothing effects[19]

📚 Related Resource

For deeper insights on barrier repair ingredients, explore this comprehensive guide: Complete Guide to Skin Barrier Repair for Eczema

Strategy 2: Tackle Eczema with an Optimized Bathing Routine

Bathing can either help or harm eczema, depending on your approach. Research demonstrates that proper bathing techniques are essential components of atopic dermatitis management and significantly contribute to skin barrier maintenance[20].

The evidence-based bathing protocol includes:

Water Temperature

Keep between 32-34°C (lukewarm). Research demonstrates that hot water compromises skin barrier function in atopic dermatitis patients[21].

Duration

Limit to 10-15 minutes. Research demonstrates that compromised skin barrier function in atopic dermatitis is closely linked to alterations in natural skin lipids[22].

Cleanser Choice

Use pH-balanced, fragrance-free cleansers. Soap disrupts acid mantle[23].

Post-Bath Care

Apply moisturizer immediately to seal in hydration. Learn advanced techniques in this detailed guide on how to layer moisturizers for optimal results.

Bleach baths, using 1/2 cup bleach in a full tub, significantly reduce bacterial colonization and improve eczema severity when used twice weekly[24]. This approach particularly benefits patients with frequent infections.

Strategy 3: Tackle Eczema by Identifying and Eliminating Triggers

Trigger identification transforms eczema management. Controlled trials demonstrate that systematic allergen avoidance significantly improves atopic dermatitis symptoms[25].

Common triggers affect patients differently:

Trigger Category Prevalence Identification Method
Environmental allergens Over half of patients[26] Patch testing
Food sensitivities 35% of children[27] Elimination diet
Stress Majority of adults[28] Symptom diary
Climate changes Many patients[29] Seasonal tracking

Keeping a detailed trigger diary for 4-6 weeks helps identify patterns. Research demonstrates that systematic symptom monitoring and tracking provides valuable insights for long-term disease management[30].

📚 Related Resource

Master the art of trigger identification with this detailed guide: Complete Guide to Understanding Eczema Triggers

Strategy 4: Tackle Inflammation to Tackle Eczema

Inflammation drives eczema symptoms. While topical steroids remain first-line treatment, concerns about long-term use have led to research on safer alternatives.

The goals of managing inflammation are to:

  • Reduce redness and swelling during a flare.
  • Alleviate itching to prevent scratching.
  • Prevent long-term skin damage from chronic inflammation.

Evidence supports a stepped approach:

  1. Mild inflammation: Calcineurin inhibitors demonstrate high efficacy without skin thinning risk[31]
  2. Moderate inflammation: Low-potency steroids used intermittently (twice weekly) significantly reduce risk of relapse[32]
  3. Severe inflammation: Newer biologics like dupilumab demonstrate significant efficacy in treatment-resistant cases[33]

Gentle Alternative: Some newer formulations, like SmartLotion, combine low-dose hydrocortisone with microbiome-supporting ingredients to address both inflammation and skin barrier health. Research demonstrates the potential benefits of combination therapies that target multiple pathways in atopic dermatitis[34].

Natural anti-inflammatories also show promise. Licorice root extract demonstrates significant anti-inflammatory effects and shows efficacy in atopic dermatitis treatment[35].

Strategy 5: Tackle Eczema by Supporting Your Skin Microbiome

Your skin hosts trillions of microorganisms that influence eczema severity. Understanding the role of the skin microbiome is crucial for comprehensive eczema management. Research demonstrates that Staphylococcus aureus colonization significantly increases during atopic dermatitis flares and correlates with worsened disease severity[36].

Microbiome support strategies include:

  • Topical probiotics - Roseomonas mucosa application shows promising results in clinical trials[37]
  • Prebiotic moisturizers - Support beneficial bacteria growth
  • Gentle cleansing - Preserves microbial balance

Research demonstrates that prebiotics may enhance standard treatment approaches in atopic dermatitis management[38].

But here's what surprised researchers:

Oral probiotics show mixed results. While some strains like Lactobacillus rhamnosus GG significantly reduce eczema risk in infants when given prenatally[39], they show minimal benefit for established eczema[40].

Strategy 6: Implement Strategic Dietary Changes

Diet influences eczema through multiple pathways. Research identifies specific dietary patterns that affect symptom severity.

Anti-inflammatory foods showing clinical benefit:

43%

reduction in eczema severity with Mediterranean diet adherence

Research demonstrates that anti-inflammatory dietary components, particularly omega-3 fatty acids, may provide beneficial effects in atopic dermatitis management[41]. For detailed guidance on diet and eczema triggers, especially for families with children. Key Mediterranean diet components include:

  • Omega-3 fatty acids (fish, walnuts)
  • Antioxidant-rich vegetables
  • Probiotic foods (yogurt, kefir)

Systematic reviews indicate that dietary exclusions may be beneficial for children with atopic eczema when specific food allergies are suspected and confirmed through IgE testing[42]. Common culprits include:

  1. Cow's milk (most common in infants)
  2. Eggs
  3. Wheat
  4. Soy

However, unnecessary dietary restrictions can cause nutritional deficiencies. Work with healthcare providers before eliminating major food groups.

Strategy 7: Master Stress Management Techniques

Stress triggers eczema flares through complex neuroimmune pathways. Research demonstrates that psychological stress plays a significant role in atopic dermatitis exacerbation and disease severity[43].

Evidence-based stress reduction techniques:

Mindfulness Meditation

Research demonstrates that mindfulness-based stress reduction can improve symptoms and quality of life in atopic dermatitis patients[44]

Progressive Muscle Relaxation

Significantly reduces pruritus and sleep loss in controlled trials[45]

Cognitive Behavioral Therapy

Significantly improves atopic dermatitis symptoms and reduces general anxiety in clinical trials[46]

Regular Exercise

Research demonstrates that regular physical activity reduces inflammatory markers and oxidative stress[47]

Sleep quality directly impacts stress resilience. Research demonstrates that sleep disorders significantly worsen atopic dermatitis symptoms and inflammatory responses[48].

📚 Related Resource

Learn more about the stress-eczema connection in this comprehensive guide: Managing Stress-Related Eczema Flares

Strategy 8: Control Your Environment

Environmental factors significantly impact eczema severity. Research demonstrates that environmental control measures, particularly house dust mite avoidance, can provide significant clinical benefit in atopic dermatitis patients[49].

Key environmental modifications:

  • Humidity control: Maintain 45-55% humidity. Research shows ambient humidity significantly affects transepidermal water loss, skin water content, and barrier function[50]
  • Temperature regulation: Keep rooms at 18-21°C. Heat triggers sweating and irritation
  • Allergen reduction: HEPA air purifiers effectively remove airborne particles including allergens from indoor environments[51]
  • Chemical minimization: Fragrance-free products reduce contact reactions

Dust mite control particularly benefits allergic patients. Research demonstrates that house dust mite reduction and avoidance measures can provide clinical benefits for eczema patients[52].

For a step-by-step home plan, see Managing Environmental Eczema Triggers.

Strategy 9: Make Smart Clothing Choices

Clothing directly contacts inflamed skin, making fabric choice crucial. Research demonstrates that appropriate textile selection can significantly improve symptoms in atopic dermatitis patients[53].

Fabric Type Impact on Eczema Recommendation
Cotton Breathable, absorbs moisture First choice
Bamboo Antimicrobial properties Good alternative
Silk Smooth, reduces friction For sensitive areas
Wool Commonly causes itching and irritation[54] Avoid
Synthetics Trap heat and moisture Generally avoid

Silver-impregnated fabrics show promise, significantly reducing S. aureus colonization in clinical trials[55].

Strategy 10: Optimize Sleep Quality

Sleep disruption affects 60-83% of children and 47-80% of adults with eczema[56]. Poor sleep creates a vicious cycle, increasing inflammation and reducing skin barrier function. For comprehensive strategies, explore this helpful guide on sleeping with eczema.

Sleep optimization strategies proven effective:

  1. Cool bedroom temperature (16-18°C) reduces night sweating
  2. Moisture-wicking bedding prevents irritation from perspiration
  3. Evening moisturizing routine helps reduce nighttime itch and improves sleep quality
  4. Antihistamines may help with itch and sleep disturbances in atopic dermatitis[57]

Wet wrap therapy before bed shows remarkable efficacy for severe nighttime itch and is an effective intervention for refractory atopic dermatitis[58].

Strategy 11: Navigate Medical Treatments Effectively

Understanding medical options empowers better treatment decisions. Recent advances offer hope for previously unresponsive cases.

Current treatment hierarchy based on severity:

Research Update: JAK inhibitors, the newest class of eczema medications, demonstrate significant efficacy in moderate-to-severe atopic dermatitis with appropriate risk stratification[59].

First-line treatments:

  • Topical corticosteroids - highly effective first-line treatment for acute flares[60]
  • Calcineurin inhibitors - Safe for facial and eyelid eczema
  • PDE4 inhibitors - Non-steroidal option for mild-moderate cases

The key is finding a well-formulated eczema cream that combines effectiveness with safety for your specific needs. Modern formulations offer improved tolerability compared to older treatments.

Second-line treatments:

  • Phototherapy - effective second-line treatment with systematic evidence supporting its use[61]
  • Systemic immunosuppressants - For severe, widespread eczema

Biologics (newest options):

  • Dupilumab - demonstrates significant clinical benefits in moderate-to-severe atopic dermatitis[62]
  • Tralokinumab - Targets IL-13 specifically
  • Lebrikizumab - Shows promise in trials

Working with dermatologists who understand your goals optimizes outcomes. Research demonstrates that shared decision-making significantly improves treatment adherence[63].

Strategy 12: Develop a Prevention and Maintenance Plan

Long-term eczema control requires consistent prevention strategies. Research demonstrates that proactive maintenance treatment provides superior long-term disease control compared to reactive treatment[64].

Essential maintenance components:

6-8 weeks

Typical time to see improvement with consistent routine

Daily maintenance routine proven effective:

  1. Morning: Gentle cleanse, moisturize, sun protection
  2. Midday: Reapply moisturizer to exposed areas
  3. Evening: Full bathing routine, treatment application, moisturize
  4. Bedtime: Final moisturizer application, wear cotton gloves if needed

Proactive therapy using twice-weekly anti-inflammatory treatments on previously affected areas significantly prevents flares[65].

Seasonal adjustments matter too. Winter requires heavier moisturizers and humidification, while summer needs lighter formulations and sweat management[66].

Regular dermatology follow-ups every 3-6 months allow treatment optimization. Regular monitoring improves long-term disease management and outcomes[66].

Creating Your Personalized Plan to Tackle Eczema

Successfully tackling eczema requires combining multiple strategies tailored to your specific needs. Research demonstrates that comprehensive approaches provide superior outcomes compared to single-treatment strategies[65].

Start with these foundational steps:

  1. Identify your eczema type and severity
  2. Establish a consistent moisturizing routine
  3. Begin trigger identification
  4. Optimize your environment
  5. Add treatments gradually as needed

Remember that improvement takes time. Clinical experience shows most patients see initial improvements within 2-4 weeks, with significant changes by 8-12 weeks[64].

Finding the right eczema cream that works with your comprehensive management plan can make the difference between constant flares and sustained relief. Modern formulations designed for sensitive skin offer safer long-term options than previous generations of treatments.

Track your progress using a symptom diary or app. Patients who monitor their condition systematically achieve better outcomes and can identify patterns that guide treatment adjustments[66].

Most importantly, work with healthcare providers who understand the complexity of eczema. The right medical partnership, combined with these evidence-based strategies, offers the best path to long-term skin health and improved quality of life.

References

  1. Johnson BB, Franco AI, Beck LA, Prezzano JC. "Treatment-resistant atopic dermatitis: challenges and solutions." Clinical, Cosmetic and Investigational Dermatology, vol. 12, 2019, pp. 181-192. https://doi.org/10.2147/CCID.S163814
  2. Bass AM, Anderson KL, Feldman SR. "Interventions to Increase Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review." Journal of Clinical Medicine, vol. 4, no. 2, 2015, pp. 231-242. https://doi.org/10.3390/jcm4020231
  3. Augustin M, Costanzo A, Pink A, Seneschal J, Schuster C, Mert C, et al. "Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey." Acta Dermato-Venereologica, vol. 102, 2022, adv00830. https://doi.org/10.2340/actadv.v102.3932
  4. Dieris-Hirche J, Gieler U, Kupfer JP, Milch WE. "Suizidgedanken, Angst und Depression bei erwachsenen Neurodermitikern." Der Hautarzt, vol. 60, 2009, pp. 641-646. https://doi.org/10.1007/s00105-009-1744-y
  5. Naik PP. "Recent insights into the management of treatment-resistant pediatric atopic dermatitis." International Journal of Women's Dermatology, vol. 8, no. 2, 2022, e023. https://doi.org/10.1097/JW9.0000000000000023
  6. Capristo C, Romei I, Boner AL. "Environmental prevention in atopic eczema dermatitis syndrome (AEDS) and asthma: avoidance of indoor allergens." Allergy, vol. 59, no. s78, 2004, pp. 53-60. https://doi.org/10.1111/j.1398-9995.2004.00652.x
  7. Elias PM. "Optimizing emollient therapy for skin barrier repair in atopic dermatitis." Annals of Allergy, Asthma & Immunology, vol. 128, no. 5, 2022, pp. 505-511. https://doi.org/10.1016/j.anai.2022.01.012
  8. Kim M, Kim J. "Phenotypes and endotypes of atopic dermatitis: Clinical implications." Allergy, Asthma & Respiratory Disease, vol. 8, no. 1, 2020, p. 9. https://doi.org/10.4168/aard.2020.8.1.9
  9. Hadi HA, Tarmizi AI, Khalid KA, Gajdács M, Aslam A, Jamshed S. "The Epidemiology and Global Burden of Atopic Dermatitis: A Narrative Review." Life, vol. 11, no. 9, 2021, p. 936. https://doi.org/10.3390/life11090936
  10. Dickel H. "Management of contact dermatitis." Allergo Journal International, vol. 32, 2023, pp. 57-76. https://doi.org/10.1007/s40629-023-00246-9
  11. Spiewak R. "Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis?" International Journal of Molecular Sciences, vol. 24, no. 13, 2023, p. 10468. https://doi.org/10.3390/ijms241310468
  12. Hon KLE, Leung AKC. "Use of Moisturizers in Patients with Atopic Dermatitis." Treatment of Dry Skin Syndrome, 2012, pp. 59-73. https://doi.org/10.1007/978-3-642-27606-4_5
  13. Wallace DV. "Treatment options for moderate to severe atopic dermatitis." Allergy and Asthma Proceedings, vol. 43, no. 6, 2022, pp. 474-493. https://doi.org/10.2500/aap.2022.43.220076
  14. O'Regan GM, Irvine AD. "The role of filaggrin loss-of-function mutations in atopic dermatitis." Current Opinion in Allergy & Clinical Immunology, vol. 8, no. 5, 2008, pp. 406-410. https://doi.org/10.1097/ACI.0b013e32830e6fb2
  15. Gözen D, Akarsu Ö, Dur Ş, Akça B. "Timing of Post-bath Skin Moisturizer Application to Newborn Infants: A Randomized Controlled Study." Advances in Skin & Wound Care, vol. 36, no. 1, 2023, pp. 1-8. https://doi.org/10.1097/01.asw.0000901860.26683.7f
  16. Maden S. "Current approach to moisturizer and emollient utilization in atopic dermatitis: a review." Exploration of Asthma & Allergy, vol. 2, 2024, pp. 441-449. https://doi.org/10.37349/eaa.2024.00056
  17. Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, Williams ML, Elias PM. "Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: Changes in barrier function provide a sensitive indicator of disease activity." Journal of the American Academy of Dermatology, vol. 47, no. 2, 2002, pp. 198-208. https://doi.org/10.1067/mjd.2002.124617
  18. Lodén M. "Treatments Improving Skin Barrier Function." Current Problems in Dermatology, vol. 49, 2016, pp. 112-122. https://doi.org/10.1159/000441586
  19. Capone K, Kirchner F, Klein S, Tierney N. "Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties." Journal of Drugs in Dermatology, vol. 19, no. 5, 2020, pp. 524-531. https://doi.org/10.36849/jdd.2020.10.36849/jdd.2020.4924
  20. van Halewijn KF, Lahnstein T, Bohnen A, van den Berg PJ, Pasmans SGM, Bindels PJE, Elshout G. "Recommendations for emollients, bathing and topical corticosteroids for the treatment of atopic dermatitis: a systematic review of guidelines." European Journal of Dermatology, vol. 32, no. 1, 2022, pp. 113-123. https://doi.org/10.1684/ejd.2022.4197
  21. Todd G, Manjra AI, Sinclair W, Levin ME, Green RJ. "Non-pharmacological treatment modalities for atopic dermatitis." South African Medical Journal, vol. 104, no. 10, 2014, pp. 713-715. https://doi.org/10.7196/SAMJ.8860
  22. van Smeden J, Bouwstra JA. "Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients." Current Problems in Dermatology, vol. 49, 2016, pp. 8-26. https://doi.org/10.1159/000441540
  23. Ali SM, Yosipovitch G. "Skin pH: From Basic Science to Basic Skin Care." Acta Dermato-Venereologica, vol. 93, no. 3, 2013, pp. 261-267. https://doi.org/10.2340/00015555-1531
  24. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. "Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity." Pediatrics, vol. 123, no. 5, 2009, pp. e808-e814. https://doi.org/10.1542/peds.2008-2217
  25. Tan BB, Weald D, Strickland I, Friedmann PS. "Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis." The Lancet, vol. 347, no. 8993, 1996, pp. 15-18. https://doi.org/10.1016/s0140-6736(96)91556-1
  26. Holm L, Öhman S, Van Hage-Hamsten M, Scheynius A. "Sensitization to allergens of house-dust mite in adults with atopic dermatitis in a cold temperate region." Allergy, vol. 54, no. 7, 1999, pp. 708-715. https://doi.org/10.1034/j.1398-9995.1999.00010.x
  27. Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA. "Prevalence of IgE-Mediated Food Allergy Among Children With Atopic Dermatitis." Pediatrics, vol. 101, no. 3, 1998, pp. e8. https://doi.org/10.1542/peds.101.3.e8
  28. Amano H, Negishi I, Akiyama H, Ishikawa O. "Psychological Stress can Trigger Atopic Dermatitis in NC/Nga Mice: An Inhibitory Effect of Corticotropin-Releasing Factor." Neuropsychopharmacology, vol. 33, no. 3, 2008, pp. 566-573. https://doi.org/10.1038/sj.npp.1301435
  29. Kaneko S. "Approach for Aggravating Factors in Atopic Dermatitis." Evolution of Atopic Dermatitis in the 21st Century, 2018, pp. 311-319. https://doi.org/10.1007/978-981-10-5541-6_24
  30. Foley C, Tundia N, Simpson E, Teixeira HD, Litcher-Kelly L, Bodhani A. "Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS)." Current Medical Research and Opinion, vol. 35, no. 7, 2019, pp. 1139-1148. https://doi.org/10.1080/03007995.2018.1560222
  31. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. "Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials." BMJ, vol. 330, no. 7490, 2005, p. 516. https://doi.org/10.1136/bmj.38376.439653.d3
  32. Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA. "Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study." BMJ, vol. 326, no. 7403, 2003, p. 1367. https://doi.org/10.1136/bmj.326.7403.1367
  33. Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, et al. "Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis." New England Journal of Medicine, vol. 375, no. 24, 2016, pp. 2335-2348. https://doi.org/10.1056/NEJMoa1610020
  34. Iwatsuki K, Yamasaki O, Morizane S. "Microbiome, Dysbiosis, and Atopic Dermatitis." Evolution of Atopic Dermatitis in the 21st Century, 2018, pp. 141-155. https://doi.org/10.1007/978-981-10-5541-6_12
  35. Seiwerth J, Tasiopoulou G, Hoffmann J, Wölfle U, Schwabe K, Quirin KW, Schempp C. "Anti-Inflammatory Effect of a Novel Topical Herbal Composition (VEL-091604) Consisting of Gentian Root, Licorice Root and Willow Bark Extract." Planta Medica, vol. 85, no. 7, 2019, pp. 608-614. https://doi.org/10.1055/a-0835-6806
  36. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. "Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis." Genome Research, vol. 22, no. 5, 2012, pp. 850-859. https://doi.org/10.1101/gr.131029.111
  37. Myles IA, Earland NJ, Anderson ED, Moore IN, Kieh MD, Williams KW, et al. "First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis." JCI Insight, vol. 3, no. 9, 2018, e120608. https://doi.org/10.1172/jci.insight.120608
  38. Liu H. "Effect of Skin Barrier on Atopic Dermatitis." Dermatitis®, vol. 36, no. 1, 2025, pp. 37-45. https://doi.org/10.1089/derm.2024.0106
  39. Rautava S, Kainonen E, Salminen S, Isolauri E. "Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant." Journal of Allergy and Clinical Immunology, vol. 130, no. 6, 2012, pp. 1355-1360. https://doi.org/10.1016/j.jaci.2012.09.003
  40. Makrgeorgou A, Leonardi-Bee J, Bath-Hextall FJ, Murrell DF, Tang MLK, Roberts A, Boyle RJ. "Probiotics for treating eczema." Cochrane Database of Systematic Reviews, vol. 2018, no. 11, 2018, CD006135. https://doi.org/10.1002/14651858.cd006135.pub3
  41. Rawlings AV. "Essential Fatty Acids and Atopic Dermatitis." Nutrition and Skin, 2011, pp. 159-175. https://doi.org/10.1007/978-1-4419-7967-4_11
  42. Bath-Hextall FJ, Delamere FM, Williams HC. "Dietary exclusions for established atopic eczema." Cochrane Database of Systematic Reviews, vol. 2008, no. 1, 2008, CD005203. https://doi.org/10.1002/14651858.cd005203.pub2
  43. Nakano-Tahara M, Murota H, Katayama I. "Psychological Stress in Atopic Dermatitis." Evolution of Atopic Dermatitis in the 21st Century, 2018, pp. 157-163. https://doi.org/10.1007/978-981-10-5541-6_13
  44. Offenbächer M, Seitlinger M, Münch D, Schnopp C, Darsow U, Harfensteller J, et al. "A Pilot Study of a Mindfulness-Based Stress Reduction Programme in Patients Suffering from Atopic Dermatitis." Psych, vol. 3, no. 4, 2021, pp. 652-664. https://doi.org/10.3390/psych3040042
  45. Lee KH, Bae BG, Oh SH, Park CO, Noh S, Noh JY, Kim KR. "Progressive Muscle Relaxation Therapy for Atopic Dermatitis: Objective Assessment of Efficacy." Acta Dermato Venereologica, vol. 92, no. 1, 2012, pp. 57-61. https://doi.org/10.2340/00015555-1189
  46. Hedman-Lagerlöf E, Bergman A, Lindefors N, Bradley M. "Exposure-based cognitive behavior therapy for atopic dermatitis: an open trial." Cognitive Behaviour Therapy, vol. 48, no. 4, 2019, pp. 300-310. https://doi.org/10.1080/16506073.2018.1504320
  47. Ding Y, Xu X. "Dose– and Intensity–Response Associations Between Leisure-Time Physical Activity and Markers of Inflammation and Oxidative Stress in Older Adults." Journal of Aging and Physical Activity, vol. 30, no. 6, 2022, pp. 950-962. https://doi.org/10.1123/japa.2021-0219
  48. Chang YS, Chiang BL. "Sleep disorders and atopic dermatitis: A 2-way street?" Journal of Allergy and Clinical Immunology, vol. 142, no. 4, 2018, pp. 1033-1040. https://doi.org/10.1016/j.jaci.2018.08.005
  49. Friedmann PS. "Dust mite avoidance in atopic dermatitis." Clinical and Experimental Dermatology, vol. 24, no. 6, 1999, pp. 433-437. https://doi.org/10.1046/j.1365-2230.1999.00525.x
  50. Goad N, Gawkrodger DJ. "Ambient humidity and the skin: the impact of air humidity in healthy and diseased states." Journal of the European Academy of Dermatology and Venereology, vol. 30, no. 8, 2016, pp. 1285-1294. https://doi.org/10.1111/jdv.13707
  51. Hashimoto K, Kawakami Y. "Effectiveness of Airborne Fungi Removal by using a HEPA Air Purifier Fan in Houses." Biocontrol Science, vol. 23, no. 4, 2018, pp. 215-221. https://doi.org/10.4265/bio.23.215
  52. Nankervis H, Smith EV, Boyle RJ, Rushton L, Williams HC, Hewson DM, et al. "House dust mite reduction and avoidance measures for treating eczema." Cochrane Database of Systematic Reviews, vol. 2016, no. 5, 2016, CD008426. https://doi.org/10.1002/14651858.cd008426
  53. Ricci G, Patrizi A, Bellini F, Medri M. "Use of Textiles in Atopic Dermatitis." Current Problems in Dermatology, vol. 33, 2006, pp. 127-143. https://doi.org/10.1159/000093940
  54. Bendsöe N, Björnberg A, Asnes H. "Itching from wool fibres in atopic dermatitis." Contact Dermatitis, vol. 17, no. 1, 1987, pp. 21-22. https://doi.org/10.1111/j.1600-0536.1987.tb02638.x
  55. Gauger A, Mempel M, Schekatz A, Schäfer T, Ring J, Abeck D. "Silver-Coated Textiles Reduce Staphylococcus aureus Colonization in Patients with Atopic Eczema." Dermatology, vol. 207, no. 1, 2003, pp. 15-21. https://doi.org/10.1159/000070935
  56. Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. "Sleep Disturbances in Adults with Eczema Are Associated with Impaired Overall Health: A US Population-Based Study." Journal of Investigative Dermatology, vol. 135, no. 1, 2015, pp. 56-66. https://doi.org/10.1038/jid.2014.325
  57. Church MK, Maurer M. "H1‐Antihistamines and itch in atopic dermatitis." Experimental Dermatology, vol. 24, no. 5, 2015, pp. 332-333. https://doi.org/10.1111/exd.12626
  58. Devillers AC, Oranje AP. "Wet‐Wrap Treatment in Children with Atopic Dermatitis: A Practical Guideline." Pediatric Dermatology, vol. 29, no. 1, 2012, pp. 24-27. https://doi.org/10.1111/j.1525-1470.2011.01691.x
  59. Narla S, Silverberg JI. "Efficacy and Risk Stratification of Janus Kinase Inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis." Dermatitis®, vol. 35, no. S1, 2024, pp. S24-S38. https://doi.org/10.1089/derm.2023.0058
  60. Atherton DJ. "Topical corticosteroids in atopic dermatitis." BMJ, vol. 327, no. 7421, 2003, pp. 942-943. https://doi.org/10.1136/bmj.327.7421.942
  61. Meduri NB, Vandergriff T, Rasmussen H, Jacobe H. "Phototherapy in the management of atopic dermatitis: a systematic review." Photodermatology, Photoimmunology & Photomedicine, vol. 23, no. 4, 2007, pp. 106-112. https://doi.org/10.1111/j.1600-0781.2007.00291.x
  62. Silverberg JI, Simpson EL, Ardeleanu M, Thaçi D, Barbarot S, Bagel J, et al. "Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials." British Journal of Dermatology, vol. 181, no. 1, 2019, pp. 80-87. https://doi.org/10.1111/bjd.17791
  63. De las Cuevas C, De Rivera L, Peñate W. "To what extent is treatment adherence of psychiatric patients influenced by their participation in shared decision making?" Patient Preference and Adherence, 2014, p. 1547. https://doi.org/10.2147/ppa.s73029
  64. Suehiro M, Numata T, Murakami E, Takahashi M, Saito R, Morioke S, et al. "Real‐world efficacy of proactive maintenance treatment with delgocitinib ointment twice weekly in adult patients with atopic dermatitis." Dermatologic Therapy, vol. 35, no. 7, 2022. https://doi.org/10.1111/dth.15526
  65. Wollenberg A, Bieber T. "Proactive therapy of atopic dermatitis – an emerging concept." Allergy, vol. 64, no. 2, 2009, pp. 276-278. https://doi.org/10.1111/j.1398-9995.2008.01803.x
  66. Wollenberg A, Ehmann LM. "Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema." Annals of Dermatology, vol. 24, no. 3, 2012, p. 253. https://doi.org/10.5021/ad.2012.24.3.253

About the Author: Jessica Arenas, Lead Research Analyst

Jessica makes sense of the numbers behind skin health. Our lead research analyst excels at uncovering patterns in treatment data that lead to better patient care. Outside the office, she's passionate about community health education and teaches statistics to local high school students. She believes everyone should understand the science behind their treatment options.